Navigation Links
New Test Identifies Heavy Drinkers
Date:7/30/2008

It compares 20 blood chemical levels to database of users, so docs can spot trouble early

WEDNESDAY, July 30 (HealthDay News) -- A new screening test identifies twice as many heavy drinkers as the commonly used liver enzyme test, a new report shows.

The Early Detection of Alcohol Consumption (EDAC) test determines the likelihood of heavy drinking in the previous four to six weeks and could help physicians spot and treat problem drinkers sooner. It uses an algorithm of 20 blood chemistry levels and compares the subject's test results to data from more than 1,700 heavy and light drinkers in a database.

The database classifies heavy drinkers as men reporting more than five drinks a day or women having more than four drinks a day.

A presentation about the test and its effectiveness was to be made Wednesday at the American Association for Clinical Chemistry (AACC) annual meeting, in Washington, D.C.

"Physicians can use the test as part of an early intervention," James Harasymiw, director of Alcohol Detection Services in Big Bend, Wisc., said in a news release issued by the AACC. "When patients are confronted with test results, they may be more likely to change their behavior."

Alcohol abuse claims about 100,000 lives in the United States annually, including almost 17,000 people who die in alcohol-related traffic accidents.

"Physicians can show patients the test results to help convince them that their drinking is causing serious damage to their organs and other biologic systems," Harasymiw said.

More information

The U.S. National Institute on Alcohol Abuse and Alcoholism has more about alcoholism.



-- Kevin McKeever



SOURCE: American Association for Clinical Chemistry, news release, July 30, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Searching for shut eye: Penn study identifies possible sleep gene
2. Has cancer spread? Research identifies best way to find answers so treatment can begin
3. Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids
4. Rutgers research identifies brain cells related to fear
5. MEDai Technology Identifies Prescription Drug Misuse
6. Penn animal study identifies new DNA weapon against avian flu
7. Leading Eating Disorder Treatment Center Identifies Popular Diet Myths
8. Large Study Identifies Most Costly Adverse Events in Childrens Hospitals
9. Large study identifies most costly adverse events in childrens hospitals
10. Weill Cornell team identifies new cancer stem cell driving metastatic tumors
11. New method identifies rat poison in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance Agency, ... Hamilton County, is embarking on a charity drive with the aim of generating ... for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... Atlanta, Georgia (PRWEB) , ... ... ... announced today it has acquired Presence Technology, S.L. (“Presence”) for a purchase ... certain price adjustments and other considerations. Presence’s annual revenue is approximately $13.2 ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
(Date:12/8/2016)... , Dec. 8, 2016  Boehringer Ingelheim announced today ... Equality Index (CEI). This is the ninth time that ... designated as a Best Place to Work for LGBT ... CEI is a national benchmarking report on corporate policies ... bisexual and transgender (LGBT) employees. "We ...
Breaking Medicine Technology: